Clinical application of melatonin

Effect of melatonin on clinical outcome of patients with repeated cycles after failed cycles of in vitro fertilization and intracytoplasmic sperm injection

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045552

Enrollment

Unknown

Registered

2021-04-19

Start date

2020-01-08

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with multiple IVF / ICSI cycles failure

Interventions

Experimental group:Added with 10-9m melatonin

Eligibility

Sex/Gender

Female

Age

22 Years to 36 Years

Inclusion criteria

Inclusion criteria: 1.At least one IVF/ICSI failed cycle; 2.Aged <= 36 years.

Exclusion criteria

Exclusion criteria: The genetic factors of infertilities of both gender.

Design outcomes

Primary

Measure	Time frame
Fertilization rate;Cleavage rate;Blastocyst rate;High quality blastocyst rate;	—

Countries

China

Contacts

Public ContactZhang Zhiguo

Reproductive Medicine Center, the First Affiliated Hospital of Anhui Medical University

zzg_100@163.com+86 18155106683

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026